2024
Hematuria Cancer Risk Score with Ultrasound Informs Cystoscopy Use in Patients with Hematuria
Tan W, Ahmad A, Zhou Y, Nathan A, Ogunbo A, Gbolahan O, Kallam N, Smith R, Khalifeh M, Tan W, Cohen D, Volanis D, Walter F, Sasieni P, Kamat A, Kelly J. Hematuria Cancer Risk Score with Ultrasound Informs Cystoscopy Use in Patients with Hematuria. European Urology Oncology 2024 PMID: 38811250, DOI: 10.1016/j.euo.2024.05.005.Peer-Reviewed Original ResearchCancer risk scoreRenal bladder ultrasoundTa bladder cancerUrinary tract cancerRisk scoreValidation cohortBladder cancerHealth care cost savingsBladder ultrasoundDiagnosis of urinary tract cancerInvasive proceduresDevelopment cohortIdentification of cancerSuspicion of bladder cancerSecondary careIndependent validation cohortReceiver operating characteristic curveUK hospitalsArea under the receiver operating characteristic curveOutcome measuresTriage of patientsConsecutive patientsPatient cohortCystoscopyHematuria
2022
A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E
Tan W, Bello A, Alvarez C, Guerrero-Ramos F, González-Padilla D, Nzeh C, de la Morena J, de Torres I, Hendricksen K, Goizueta F, Del Álamo J, Chiancone F, Fedelini P, Poggio M, Porpiglia F, Rodríguez V, Torres J, Wilby D, Robinson R, Sousa-Escandón A, Mata J, Moreno J, Molina F, Semino M, Stemberger A, Escudero J, Redorta J, Tan W. A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E. Bladder Cancer 2022, 8: 379-393. PMID: 38994184, PMCID: PMC11181696, DOI: 10.3233/blc-220026.Peer-Reviewed Original ResearchNon-muscle invasive bladder cancerTransurethral resection of bladder tumorRecurrence-free survivalProgression-free survivalInvasive bladder cancerMitomycin CBCG-naiveBladder cancerAdverse eventsTreated with intravesical bacillus Calmette-GuerinTreatment of non-muscle invasive bladder cancerIntravesical bacillus Calmette-GuerinResection of bladder tumorTreating non-muscle invasive bladder cancerFavorable adverse event profileAdverse event profileBacillus Calmette-GuerinMinor adverse eventsMulti-institutional studyBCG failurePapillary diseaseTransurethral resectionBladder tumorsConsecutive patientsMedian ageRetzius-sparing technique independently predicts early recovery of urinary continence after robot-assisted radical prostatectomy
Kadhim H, Ang K, Tan W, Nathan A, Pavan N, Mazzon G, Al-Kadhi O, Di G, Dinneen E, Briggs T, Kelkar A, Rajan P, Nathan S, Kelly J, Sooriakumaran P, Sridhar A. Retzius-sparing technique independently predicts early recovery of urinary continence after robot-assisted radical prostatectomy. Journal Of Robotic Surgery 2022, 16: 1419-1426. PMID: 35192106, DOI: 10.1007/s11701-022-01383-z.Peer-Reviewed Original ResearchConceptsRobot-assisted radical prostatectomySocial urinary continenceBody mass indexNeurovascular bundle sparingRetzius-sparing techniqueRS-RARPUrinary continenceNeurovascular bundleRadical prostatectomyEarly recovery of urinary continenceRecovery of urinary continenceMedian body mass indexMultivariate logistic regression analysisMembranous urethral lengthLocalised prostate cancerHigh-volume institutionsSurgical treatment optionsFollow-up dataLogistic regression analysisConsecutive patientsAssociated with recoveryPad useUrethral lengthMedian ageProstate cancer